Developer docs
API playgroundTry for free, no card

Search company profiles

EarlySense

Full company profile

uuid00029wn

Namestring
EarlySense
Websiteurl
earlysense.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

EarlySense is an Israel-based healthcare technology company, founded in 2004 and headquartered in Ramat Gan, that has developed a contact-free continuous patient monitoring system for general care hospital settings. The system's proprietary sensor technology tracks heart rate, respiratory rate, and patient motion without physical contact with the patient, and delivers real-time alerts to nursing staff through central stations, large screens, and handheld devices. It is positioned to address three clinical use cases — early detection of patient deterioration, fall prevention, and pressure ulcer prevention — in general care wards where patients are otherwise checked only every four to six hours by nursing staff.

The company operates an enterprise B2B sales motion, selling hardware-based monitoring systems directly to healthcare facilities. Pricing is not publicly disclosed. EarlySense has raised approximately $131 million across 11 funding rounds since 2005, with strategic investors including Hill-Rom (a major hospital bed OEM), Wells Fargo Strategic Capital, Samsung Ventures, Mitsui & Co, and Welch Allyn participating alongside recurring financial investors Pitango VC and JK&B Capital. The most recent disclosed round was $39 million in January 2019, which valued the company at $325 million post-money on a $260 million pre-money basis. The company operates with approximately 68 employees under co-founder and CEO Avner Halperin, with CTO Guy Merger overseeing R&D and a dedicated VP of Clinical and Regulatory Affairs indicating active medical device compliance work. The recurring presence of hospital infrastructure and medical device strategics in the cap table points to embedded distribution channels rather than a pure standalone vendor model.

No revenue figure, named customer accounts, post-2019 funding event, or subsequent product launch are disclosed in the available source data, which limits visibility into current commercial scale and momentum.

Short descriptiontext

EarlySense develops a contact-free continuous patient monitoring system for general care hospital patients, tracking heart rate, respiratory rate, and motion without physical contact and delivering real-time alerts to nursing staff for early deterioration, fall, and pressure ulcer prevention.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWoburn, United States
HQ citystring
Woburn
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
continuous patient monitoring, contact-free sensing, remote patient monitoring, clinical surveillance systems, vital sign monitoring
Industry3 codes
PRIMARYHLAHACAA
Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAG
Fall Detection, Safety & Emergency Response (PERS, Smart Home Health Sensors)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Patient Monitoring Systems
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Monitoring System Sales
TypeHardware Sales
Description

Sale of continuous patient monitoring systems to healthcare facilities with real-time alerting capabilities for clinical use in general care settings.

startuphub.ai
Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

EarlySense develops and sells EverOn, a contact-free continuous patient monitoring system that tracks heart rate, respiratory rate, and motion without physical contact. The system is designed for general care hospital patients, delivering real-time alerts to nursing staff through central stations, large screens, and handheld devices to enable early detection of patient deterioration, fall prevention, and pressure ulcer prevention.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

EarlySense offers a single unified continuous patient monitoring system designed for general care patients. The system non-contactedly tracks heart rate, respiratory rate, and motion, delivering real-time alerts to nursing staff via central stations, large screens, and handheld devices. It serves three primary clinical use cases: early detection of patient deterioration, fall prevention, and pressure ulcer prevention.

Product and service1 record
1EarlySense Continuous Patient Monitoring System (EverOn)
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Caretaker Medical makes a continuous, non-invasive "cNIBP" vital signs monitor that tracks blood pressure, heart rate, and respiratory rate without cuffs or contact. It is the closest direct competitor to EarlySense's contact-free ward-monitoring approach.

TypeDirect peer
Description

Masimo is a global patient monitoring leader with continuous SpO2, respiratory, and pulse-rate sensors used across general care, step-down, and ICU settings. Its wearable and bedside monitoring portfolio competes head-to-head with EarlySense in the same hospital vital-signs category.

TypeEmerging player
Description

Biobeat offers a remote patient monitoring platform with chest-worn and wearable sensors that continuously measure vital signs including heart rate, respiratory rate, blood pressure, and temperature. It overlaps with EarlySense in continuous vital-sign monitoring but uses a wearable rather than contact-free form factor.

TypeBroad incumbent
Description

Philips Patient Monitoring provides IntelliVue and wearable biosensor solutions across ICU, step-down, and general care. As a global incumbent with broad hospital IT integration, Philips competes directly with EarlySense in continuous ward monitoring while bundling monitoring into larger enterprise contracts.

TypeBroad incumbent
Description

GE HealthCare's Patient Care Solutions includes bedside monitors, wearable sensors (Portrait Mobile), and central stations for continuous vital signs. It competes with EarlySense in the general-care monitoring category and brings stronger ICU telemetry and EMR integration.

TypeBroad incumbent
Description

Mindray is a leading global patient monitoring and in-vitro diagnostics vendor with ePM and BeneVision series monitors covering ICU through general wards. It competes with EarlySense on continuous vital signs and benefits from strong price competitiveness, particularly in international markets.

7Nihon Kohden
TypeDirect peer
Description

Nihon Kohden provides bedside and central-station patient monitoring with continuous ECG, SpO2, and respiratory monitoring for general wards and ICUs. Its Life Scope and wearable SMS solutions overlap with EarlySense's continuous ward-monitoring use case.

8Drägerwerk
TypeBroad incumbent
Description

Dräger provides Infinity patient monitoring, anesthesia, and acute-care solutions used in hospitals worldwide. Its general-ward and intermediate-care monitoring competes with EarlySense and adds established ventilator and therapy integration.

TypeEmerging player
Description

iRhythm's Zio long-term cardiac monitor continuously captures ECG data outside the hospital. It is an emerging adjacent player in continuous ambulatory monitoring, addressing similar "gap between episodic checks" pain points that EarlySense targets on the inpatient side.

TypeEmerging player
Description

Vivify Health provides a remote patient monitoring platform used by health systems and payers for post-acute and chronic care management. It is an emerging player whose connected vital-signs kits and RPM workflows are complementary/competing with EarlySense's home-monitoring expansion path.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors17 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EarlySense

Patient Monitoring Systemsearlysense.com

EarlySense develops a contact-free continuous patient monitoring system for general care hospital patients, tracking heart rate, respiratory rate, and motion without physical contact and delivering real-time alerts to nursing staff for early deterioration, fall, and pressure ulcer prevention.

What EarlySense does

EarlySense is an Israel-based healthcare technology company, founded in 2004 and headquartered in Ramat Gan, that has developed a contact-free continuous patient monitoring system for general care hospital settings. The system's proprietary sensor technology tracks heart rate, respiratory rate, and patient motion without physical contact with the patient, and delivers real-time alerts to nursing staff through central stations, large screens, and handheld devices. It is positioned to address three clinical use cases — early detection of patient deterioration, fall prevention, and pressure ulcer prevention — in general care wards where patients are otherwise checked only every four to six hours by nursing staff.

The company operates an enterprise B2B sales motion, selling hardware-based monitoring systems directly to healthcare facilities. Pricing is not publicly disclosed. EarlySense has raised approximately $131 million across 11 funding rounds since 2005, with strategic investors including Hill-Rom (a major hospital bed OEM), Wells Fargo Strategic Capital, Samsung Ventures, Mitsui & Co, and Welch Allyn participating alongside recurring financial investors Pitango VC and JK&B Capital. The most recent disclosed round was $39 million in January 2019, which valued the company at $325 million post-money on a $260 million pre-money basis. The company operates with approximately 68 employees under co-founder and CEO Avner Halperin, with CTO Guy Merger overseeing R&D and a dedicated VP of Clinical and Regulatory Affairs indicating active medical device compliance work. The recurring presence of hospital infrastructure and medical device strategics in the cap table points to embedded distribution channels rather than a pure standalone vendor model.

No revenue figure, named customer accounts, post-2019 funding event, or subsequent product launch are disclosed in the available source data, which limits visibility into current commercial scale and momentum.

EarlySense firmographics

Firmographics
Name
EarlySense
Website
https://earlysense.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
EarlySense develops a contact-free continuous patient monitoring system for general care hospital patients, tracking heart rate, respiratory rate, and motion without physical contact and delivering real-time alerts to nursing staff for early deterioration, fall, and pressure ulcer prevention.
Ownership category
akta.pro rank

EarlySense industry classification

Industry
Product category
Patient Monitoring Systems
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHACAA
Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAG
Fall Detection, Safety & Emergency Response (PERS, Smart Home Health Sensors)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

  • Continuous patient monitoring
  • Contact-free sensing
  • Remote patient monitoring
  • Clinical surveillance systems
  • Vital sign monitoring

Where EarlySense is headquartered

Location

Headquarters

HQ city
Woburn
HQ country
United States
HQ region
North America

Markets served

EarlySense business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Healthcare Monitoring System Sales: Sale of continuous patient monitoring systems to healthcare facilities with real-time alerting capabilities for clinical use in general care settings.

Go-to-market motion1 record

EarlySense product offering

Product offering

Core offering

EarlySense develops and sells EverOn, a contact-free continuous patient monitoring system that tracks heart rate, respiratory rate, and motion without physical contact. The system is designed for general care hospital patients, delivering real-time alerts to nursing staff through central stations, large screens, and handheld devices to enable early detection of patient deterioration, fall prevention, and pressure ulcer prevention.

Product overview

EarlySense offers a single unified continuous patient monitoring system designed for general care patients. The system non-contactedly tracks heart rate, respiratory rate, and motion, delivering real-time alerts to nursing staff via central stations, large screens, and handheld devices. It serves three primary clinical use cases: early detection of patient deterioration, fall prevention, and pressure ulcer prevention.

Differentiator

Problem solved

Functional benefit

Products and services

  • EarlySense Continuous Patient Monitoring System (EverOn)

Companies that use EarlySense

Customer profile

Segments1 record

Ideal customer profiles1 record

EarlySense technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

EarlySense partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

EarlySense competitors and assessment

Company assessment

Direct peers

  • Caretaker Medical: Caretaker Medical makes a continuous, non-invasive "cNIBP" vital signs monitor that tracks blood pressure, heart rate, and respiratory rate without cuffs or contact. It is the closest direct competitor to EarlySense's contact-free ward-monitoring approach.
  • Masimo: Masimo is a global patient monitoring leader with continuous SpO2, respiratory, and pulse-rate sensors used across general care, step-down, and ICU settings. Its wearable and bedside monitoring portfolio competes head-to-head with EarlySense in the same hospital vital-signs category.
  • Nihon Kohden: Nihon Kohden provides bedside and central-station patient monitoring with continuous ECG, SpO2, and respiratory monitoring for general wards and ICUs. Its Life Scope and wearable SMS solutions overlap with EarlySense's continuous ward-monitoring use case.

Emerging players

  • Biobeat: Biobeat offers a remote patient monitoring platform with chest-worn and wearable sensors that continuously measure vital signs including heart rate, respiratory rate, blood pressure, and temperature. It overlaps with EarlySense in continuous vital-sign monitoring but uses a wearable rather than contact-free form factor.
  • iRhythm Technologies: iRhythm's Zio long-term cardiac monitor continuously captures ECG data outside the hospital. It is an emerging adjacent player in continuous ambulatory monitoring, addressing similar "gap between episodic checks" pain points that EarlySense targets on the inpatient side.
  • Vivify Health: Vivify Health provides a remote patient monitoring platform used by health systems and payers for post-acute and chronic care management. It is an emerging player whose connected vital-signs kits and RPM workflows are complementary/competing with EarlySense's home-monitoring expansion path.

Broad incumbents

  • Philips (Patient Monitoring): Philips Patient Monitoring provides IntelliVue and wearable biosensor solutions across ICU, step-down, and general care. As a global incumbent with broad hospital IT integration, Philips competes directly with EarlySense in continuous ward monitoring while bundling monitoring into larger enterprise contracts.
  • GE HealthCare: GE HealthCare's Patient Care Solutions includes bedside monitors, wearable sensors (Portrait Mobile), and central stations for continuous vital signs. It competes with EarlySense in the general-care monitoring category and brings stronger ICU telemetry and EMR integration.
  • Mindray: Mindray is a leading global patient monitoring and in-vitro diagnostics vendor with ePM and BeneVision series monitors covering ICU through general wards. It competes with EarlySense on continuous vital signs and benefits from strong price competitiveness, particularly in international markets.
  • Drägerwerk: Dräger provides Infinity patient monitoring, anesthesia, and acute-care solutions used in hospitals worldwide. Its general-ward and intermediate-care monitoring competes with EarlySense and adds established ventilator and therapy integration.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

EarlySense social profiles

Digital presence

EarlySense financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EarlySense leadership team

Management profile

Number of profiles

Profiles6 records

EarlySense funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EarlySense M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EarlySense

What does EarlySense do?

EarlySense develops and sells EverOn, a contact-free continuous patient monitoring system that tracks heart rate, respiratory rate, and motion without physical contact. The system is designed for general care hospital patients, delivering real-time alerts to nursing staff through central stations, large screens, and handheld devices to enable early detection of patient deterioration, fall prevention, and pressure ulcer prevention.

Is EarlySense a public or private company?

EarlySense is a private company. It is classified as venture growth investor backed and is currently operating.

When was EarlySense founded?

EarlySense was founded in 2004. It employs 11 to 50 people.

Where is EarlySense based?

EarlySense is headquartered in Woburn, United States, in the North America region.

How does EarlySense make money?

One revenue line is on record: healthcare Monitoring System Sales.

Who are EarlySense's main competitors?

Direct peers on record are Caretaker Medical, Masimo and Nihon Kohden. Emerging players are Biobeat, iRhythm Technologies and Vivify Health. Broad incumbents are Philips (Patient Monitoring), GE HealthCare, Mindray and Drägerwerk.

Does EarlySense have an API?

No public API is recorded for EarlySense.

What industry is EarlySense in?

EarlySense's product category is Patient Monitoring Systems. Its primary akta.pro industry code is HLAHACAA, Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SeedtableExplore 69 Best Biosensor Startups to watch in 2025. Discover innovative companies, funding insights, and industry trends.The article presents a curated list of 69 biosensor startups to watch in 2025, highlighting specific companies such as EarlySense, inne, and Meltin MMI alongside their funding details and technological focus areas. It provides an overview of industry trends within gerontechnology, fertility, robotics, and healthcare diagnostics across global locations including Israel, Germany, Japan, and the United States. The content serves as an informational directory for investors and industry observers interested in the biosensor sector's innovation landscape.PR Newswire"Health at Home: New Era of Healthcare"EarlySense announced its research sponsorship with Parks Associates and the release of a whitepaper titled 'Health at Home: New Era of Healthcare' at the CONNECTIONS Summit during CES 2022 in Las Vegas. The whitepaper examines factors driving the shift from facility-centric care to healthcare at home, including reimbursement changes, regulatory changes, new funding, staffing shortages, device innovation, and consumer demand. The research indicates the pandemic accelerated the remote health technology market 5-10 years beyond pre-pandemic expectations.PR NewswireEarlySense® Showcases its Award-winning InSight+® System at CES 2022EarlySense, a market leader in contact-free continuous monitoring solutions, showcased its InSight+ system as a CES 2022 Innovation Awards Honoree at the CES trade show in Las Vegas. The system, powered by AT&T IoT connectivity, uses under-the-mattress sensors to continuously and passively collect patient biometrics including vital signs, sleep data, and clinical alerts for remote patient monitoring. EarlySense plans to make InSight+ available for clinical research purposes first, with general availability targeted for the second half of 2022, targeting growth in home-based virtual care solutions.PR NewswireParks Associates: Ten Percent of US Broadband Households own a Smart Sleep Product, Such as Smart Mattresses and Stand-Alone Sleep MonitorsParks Associates, in partnership with EarlySense, released a whitepaper reporting that 10% of US broadband households now own a smart sleep product and 64% used telehealth services in 2021, marking a significant shift toward healthcare at home. The research also found that over half of US broadband households own at least one connected health device, up dramatically from 2020. The findings indicate that the pandemic has accelerated consumer adoption of remote patient monitoring and virtual care solutions.PR NewswireEarlySense® InSight+® Earns CES 2022 Innovation AwardEarlySense's InSight+ contact-free monitoring system won a CES 2022 Innovation Award. The under-the-mattress sensor collects vital signs and sleep data, using AI to flag early deterioration. The company will showcase it at CES 2022.PR NewswireEarlySense® Offers "Vital Insights" for Healthcare ProvidersEarlySense, a market leader in contact-free continuous monitoring solutions, announced the launch of a new podcast series called 'Vital Insights' and a resource library during Telehealth Awareness Week to help healthcare providers navigate virtual care and remote patient monitoring implementation. The podcast series features in-depth interviews with thought leaders across health technology sectors, covering topics including AI, pandemic effects, Hospital@Home, and clinical validation, while the resource library focuses on clinical intelligence, infrastructure, interoperability, and reimbursement policy. EarlySense is based in Ramat Gan, Israel and Woburn, Massachusetts, with partnerships including Samsung, Welch Allyn, iFit, and Beurer.PR NewswireInsight from the Front Lines: New Survey Looks to Identify Challenges in Virtual CareEarlySense, a provider of contact-free continuous monitoring solutions, announced a new 30-question survey titled 'Finding the Gaps in Technology: Virtual Care Assessment' during Telehealth Awareness Week, aimed at identifying benefits and pain points in virtual care and remote patient monitoring. The survey, which runs from September 17 to November 19, 2021, focuses on technology adoption, impact on patient care, implementation gaps, and opportunities for improving clinician efficiency. Findings from the survey will be announced during the first week of December 2021.PR NewswireEarlySense® Announces Sponsorship of First-ever Telehealth Awareness WeekEarlySense, a market leader in contact-free continuous monitoring solutions, announced its sponsorship of the inaugural Telehealth Awareness Week (September 19-25, 2021), presented by the American Telemedicine Association. The week will feature events and informational resources to advance telehealth and remote patient monitoring across the care continuum in the United States. EarlySense's Chief Product Officer highlighted ongoing challenges including patient compliance, reimbursement expansion, interoperability, and patient education.GlobesHillrom buys medical monitoring tech from EarlySenseHillrom acquired EarlySense's contact-free continuous monitoring technology for $30 million, plus milestone payments and equity. The tech monitors heart and respiratory rates over 100 times per minute and has monitored over one million patients. EarlySense will license the IP for use outside hospitals.PR NewswireEarlySense to Accelerate Growth in Remote Patient Monitoring Sector With Sale of Contact-Free Monitoring Technology To HillromEarlySense has sold its proprietary contact-free continuous monitoring technology to Hillrom for $30 million, along with additional potential payments based on future milestones. This agreement enables EarlySense to focus on the growing market for remote patient monitoring, leveraging their technology that has already saved thousands of lives. The transaction is part of a broader opportunity created by the COVID-19 pandemic to enhance smart health technologies beyond hospitals.